Kit comprising a packaging material and a solid pharmaceutical or nutraceutical product contained in the packaging material
US9414988B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Sep 4, 2012 |
| Grant date | Aug 16, 2016 |
| Priority date | — |
| Expiry date | Jun 24, 2033 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D81/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A kit including a packaging material and a solid pharmaceutical or nutraceutical product, and in particular for a solid, opioid-based pharmaceutical product. The packaging material has an inner surface and an outer surface that avoids contamination of the product. At least that part of the inner surface, which is exposed to the pharmaceutical or nutraceutical product, is made of or covered with an inert material selected from the group made of polyamide, polyethylene terephthalate and epoxy resin-coated aluminium. The solid pharmaceutical or nutraceutical product is either a solid, opioid-based pharmaceutical product or is selected from the group made of acemetacin, amitriptyline, amobarbital, butalbital, carbachol, citric acid, dexmethylphenidate, fluoxetine, mephobarbital, metamizole, methadone, methylphenidate, methylphenobarbital, nicotine, nifedipine, oxprenolol, oxyconazole, pentobarbital, phenobarbital, phentermine, primidone, proparacaine, propoxyphene, secobarbital, selegiline, tetrahydropapaverine, trimethobenzamide, and mixtures thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.